RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/32877502http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/32877502http://www.w3.org/2000/01/rdf-schema#comment"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious respiratory virus that can lead to venous/arterial thrombosis, stroke, renal failure, myocardial infarction, thrombocytopenia, and other end-organ damage. Animal models demonstrating end-organ protection in C3-deficient mice and evidence of complement activation in humans have led to the hypothesis that SARS-CoV-2 triggers complement-mediated endothelial damage, but the mechanism is unclear. Here, we demonstrate that the SARS-CoV-2 spike protein (subunit 1 and 2), but not the N protein, directly activates the alternative pathway of complement (APC). Complement-dependent killing using the modified Ham test is blocked by either C5 or factor D inhibition. C3 fragments and C5b-9 are deposited on TF1PIGAnull target cells, and complement factor Bb is increased in the supernatant from spike protein-treated cells. C5 inhibition prevents the accumulation of C5b-9 on cells, but not C3c; however, factor D inhibition prevents both C3c and C5b-9 accumulation. Addition of factor H mitigates the complement attack. In conclusion, SARS-CoV-2 spike proteins convert nonactivator surfaces to activator surfaces by preventing the inactivation of the cell-surface APC convertase. APC activation may explain many of the clinical manifestations (microangiopathy, thrombocytopenia, renal injury, and thrombophilia) of COVID-19 that are also observed in other complement-driven diseases such as atypical hemolytic uremic syndrome and catastrophic antiphospholipid antibody syndrome. C5 inhibition prevents accumulation of C5b-9 in vitro but does not prevent upstream complement activation in response to SARS-CoV-2 spike proteins."xsd:string
http://purl.uniprot.org/citations/32877502http://purl.org/dc/terms/identifier"doi:10.1182/blood.2020008248"xsd:string
http://purl.uniprot.org/citations/32877502http://purl.uniprot.org/core/author"Chen H."xsd:string
http://purl.uniprot.org/citations/32877502http://purl.uniprot.org/core/author"Yu J."xsd:string
http://purl.uniprot.org/citations/32877502http://purl.uniprot.org/core/author"Yuan X."xsd:string
http://purl.uniprot.org/citations/32877502http://purl.uniprot.org/core/author"Chaturvedi S."xsd:string
http://purl.uniprot.org/citations/32877502http://purl.uniprot.org/core/author"Braunstein E.M."xsd:string
http://purl.uniprot.org/citations/32877502http://purl.uniprot.org/core/author"Brodsky R.A."xsd:string
http://purl.uniprot.org/citations/32877502http://purl.uniprot.org/core/date"2020"xsd:gYear
http://purl.uniprot.org/citations/32877502http://purl.uniprot.org/core/name"Blood"xsd:string
http://purl.uniprot.org/citations/32877502http://purl.uniprot.org/core/pages"2080-2089"xsd:string
http://purl.uniprot.org/citations/32877502http://purl.uniprot.org/core/title"Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition."xsd:string
http://purl.uniprot.org/citations/32877502http://purl.uniprot.org/core/volume"136"xsd:string
http://purl.uniprot.org/citations/32877502http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/32877502
http://purl.uniprot.org/citations/32877502http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/32877502
http://purl.uniprot.org/uniprot/#_A6XNE2-mappedCitation-32877502http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/32877502
http://purl.uniprot.org/uniprot/#_K7ERG9-mappedCitation-32877502http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/32877502
http://purl.uniprot.org/uniprot/#_P00746-mappedCitation-32877502http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/32877502
http://purl.uniprot.org/uniprot/#_Q6FHW3-mappedCitation-32877502http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/32877502
http://purl.uniprot.org/uniprot/P00746http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/32877502
http://purl.uniprot.org/uniprot/A6XNE2http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/32877502
http://purl.uniprot.org/uniprot/Q6FHW3http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/32877502
http://purl.uniprot.org/uniprot/K7ERG9http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/32877502